Next Article in Journal
Sensors: Views of Staff of a Disability Service Organization
Previous Article in Journal
Structured Decision-Making: Using Personalized Medicine to Improve the Value of Cancer Care
Article Menu

Export Article

Open AccessOpinion
J. Pers. Med. 2013, 3(1), 14-22;

Driving Forces Behind the Past and Future Emergence of Personalized Medicine

Imperial College London, Exhibition Road, London SW7 2AZ, UK
Christian-Albrechts-University Kiel, Christian-Albrechts-Platz 4, 24118 Kiel, Germany
Author to whom correspondence should be addressed.
Received: 23 November 2012 / Revised: 14 January 2013 / Accepted: 14 January 2013 / Published: 17 January 2013
Full-Text   |   PDF [310 KB, uploaded 17 January 2013]   |  


Personalized medicine can be seen as a continuously developing approach to tailoring treatments according to the individual characteristics of a patient. In some way, medicine has always been personalized. During the last decade, however, scientific and technological progress have made truly personalized healthcare increasingly become reality. Today’s personalized medicine involves targeted therapies and diagnostic tests. The development of targeted agents represents a major investment opportunity to pharmaceutical companies, which have been facing the need to diversify their business due to an increasingly challenging market place. By investing into the development of personalized therapies, pharmaceutical companies mitigate a major part of the risks posed by factors such as patent expiries or generic competition. Viewing upon personalized medicine from different perspectives points out the multi-causality of its emergence. Research efforts and business diversification have been two main driving forces; they do supplement each other, however, are not jointly exhaustive in explaining the emergence of this approach. Especially in the future, a number of further stakeholders will impact the evolution of personalized medicine. View Full-Text
Keywords: personalized healthcare; diagnostic testing; genomic medicine; business diversification personalized healthcare; diagnostic testing; genomic medicine; business diversification

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Steffen, J.A.; Steffen, J.S. Driving Forces Behind the Past and Future Emergence of Personalized Medicine. J. Pers. Med. 2013, 3, 14-22.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top